UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.59B |
| 2 |
AGN
Allergan plc
AGN
|
+$763M |
| 3 |
Boeing
BA
|
+$639M |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$542M |
| 5 |
Apple
AAPL
|
+$402M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$377M |
| 2 |
Ecolab
ECL
|
+$332M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$315M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$306M |
| 5 |
CELG
Celgene Corp
CELG
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.74% |
| 2 | Financials | 7.41% |
| 3 | Healthcare | 6.49% |
| 4 | Consumer Discretionary | 5.87% |
| 5 | Industrials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
CALL
EQT Corp
EQT
$33.3B
| $8.39M | ﹤0.01% |
530,600
+505,600
| +2,022% | +$9.7M |
|
|
KIO
1902
KKR Income Opportunities Fund
KIO
$451M
| $8.37M | ﹤0.01% |
532,152
-8,184
| -2% | -$129K |
|
1903
PUT
Bausch Health
BHC
$2.58B
| $8.36M | ﹤0.01% |
331,400
-23,000
| -6% | -$546K |
|
1904
BioCryst Pharmaceuticals
BCRX
$2.28B
| $8.35M | ﹤0.01% |
2,202,794
+1,691,681
| +331% | +$10.2M |
|
1905
Bruker
BRKR
$9.57B
| $8.35M | ﹤0.01% |
167,115
+143,669
| +613% | +$6.05M |
|
1906
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$8.71B
| $8.35M | ﹤0.01% |
219,376
+15,493
| +8% | +$587K |
|
1907
Sunoco
SUN
$14.4B
| $8.34M | ﹤0.01% |
266,492
-29,723
| -10% | -$912K |
|
|
CDK
1908
DELISTED
CDK Global, Inc.
CDK
| $8.33M | ﹤0.01% |
168,546
-19,942
| -11% | -$1.07M |
|
|
OPP
1909
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$190M
| $8.31M | ﹤0.01% |
493,044
+8,383
| +2% | +$141K |
|
1910
Antero Midstream
AM
$10.4B
| $8.31M | ﹤0.01% |
725,045
-5,803,219
| -89% | -$74.3M |
|
1911
BlackRock Enhanced Global Dividend Trust
BOE
$673M
| $8.3M | ﹤0.01% |
773,217
+20,940
| +3% | +$221K |
|
1912
CALL
Altria Group
MO
$114B
| $8.27M | ﹤0.01% |
174,600
-85,300
| -33% | -$4.47M |
|
|
UMPQ
1913
DELISTED
Umpqua Holdings Corp
UMPQ
| $8.21M | ﹤0.01% |
494,575
+19,825
| +4% | +$335K |
|
|
CONE
1914
DELISTED
CyrusOne Inc Common Stock
CONE
| $8.17M | ﹤0.01% |
141,496
-22,887
| -14% | -$1.34M |
|
1915
InterDigital
IDCC
$7.87B
| $8.15M | ﹤0.01% |
126,512
+73,112
| +137% | +$4.88M |
|
1916
Qorvo
QRVO
$7.99B
| $8.14M | ﹤0.01% |
122,206
+41,348
| +51% | +$2.87M |
|
1917
Nuveen Credit Strategies Income Fund
JQC
$704M
| $8.14M | ﹤0.01% |
1,027,387
+14,947
| +1% | +$118K |
|
1918
iShares Residential and Multisector Real Estate ETF
REZ
$879M
| $8.12M | ﹤0.01% |
111,366
+105,765
| +1,888% | +$7.57M |
|
1919
United States Oil Fund
USO
$2.02B
| $8.12M | ﹤0.01% |
84,260
-225
| -0.3% | -$22.4K |
|
1920
CALL
lululemon athletica
LULU
$13.5B
| $8.11M | ﹤0.01% |
+45,000
| New | +$7.82M |
|
1921
Banner Corp
BANR
$2.39B
| $8.11M | ﹤0.01% |
149,738
+146,183
| +4,112% | +$7.84M |
|
|
MDCO
1922
DELISTED
Medicines Co
MDCO
| $8.1M | ﹤0.01% |
222,094
-285,428
| -56% | -$9.32M |
|
1923
CALL
Bunge Global
BG
$20.4B
| $8.1M | ﹤0.01% |
+145,300
| New | +$7.75M |
|
1924
State Street SPDR Dow Jones International Real Estate ETF
RWX
$269M
| $8.1M | ﹤0.01% |
208,915
+62,170
| +42% | +$2.41M |
|
1925
Park Hotels & Resorts
PK
$3.03B
| $8.08M | ﹤0.01% |
293,233
+22,208
| +8% | +$666K |
|
Similar funds
UBS Group's Q2 2019 Portfolio in Review
As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $9.95B of net new capital in Q2 2019, opening 810 new positions and adding to 3,919 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.
- UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
- UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
- UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
- UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
- UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
- UBS Group opened 810 new positions and closed 626 in Q2 2019.
- UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.
Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.